SCNXScienture Holdings, Inc.
Is Scienture Holdings struggling financially?
Yes, by its own account. Scienture Holdings told the SEC on 15 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.
Going concern disclosed May 2026
15/100
Critical
- Sector
- Biotech/Pharma
- Market cap
- $18.5M
- Source filing
- 10-Q 15 May 2026
- Balance sheet
- 30 Jun 2026
Cash runway
-
3months
If the burn speeds up
Empty by Sep 2026
-
6months
If it eases off
Empty by Dec 2026
Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.
Out of cashTwo years or more
The runway math
Cash and short-term investments
$8.2M
÷
Cash burned over the last 12 months
$22.4M
What Scienture Holdings told the SEC
…limited to: Our limited amount of cash; The negative effect on our business and our ability to raise capital that is created by the fact that there is a substantial doubt about our ability to continue as a going concern; Our limited revenue generating operations, and risks of our operations not being profitable; Claims relating to alleged violations of intellectual property rights of others;…
Scienture Holdings, Inc., Form 10-Q, filed 15 May 2026.
Read the filing on SEC.govWhat this means
- Not a bankruptcy filing, and not a prediction.
- It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
- The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.
What else the numbers show
- 234.5% share-count increase The company issued stock. Each share now owns 70.1% less of the business than a year ago, before any change in the price.
Other Biotech/Pharma companies that filed the doubt
- NUWE Nuwellis $4.2M
- PASG Passage BIO $14.3M
- HOWL Werewolf Therapeutics $42.5M
- HYPD Hyperion Defi $49.4M
- INBS Intelligent Bio Solutions $7.6M
- ONCO Onconetix $2.6M